The objective of the existing research was formulation development and preparation of microemulsion loaded emulgel in augmenting the topical delivery of Lornoxicam. Emulsion and gel combined are recognized as Emulgels. Gelling agents Carbopol 940, 974, 980 were used to formulating Lornoxicam emulgel. The drug release from emulgel was determined depending on the different gelling agents. Clove oil for internal phase and Polyethylene glycol 200 was applied as co-surfactant and Tween 20 as permeation enhancer. Prepared emulgels were evaluated for in-vitro and in- vivo anti-inflammatory activity using Albino mice and stability studies. The optimized batch of emulgel gave better results when compared with the marketed Diclofenac sodium gel. 90.42% drug release was detected in 8 hr. Prepared formulation was free from skin irritation and detected with 62.02% inhibition of edema. Correspondingly, prepared formulations were found to be stable. Developed microemulsion increased solubility of drugs, so that less soluble drugs can be applied in the formulation. Carbopol 980 (1.5 %) gave better results for emulgel. Therefore, microemulsion-loaded Lornoxicam Emulgel detected with better analgesic effect.
29 September 2022 in Biosciences Biotechnology Research Asia
The development of Esomeprazole microspheres using enteric coated polymers, such as Eudragit L100, by antisolvent precipitation method has been the focus of recent research in order to achieve the best drug concentration along with improved stability and bioavailability without any adverse effects in an acidic environment. For the development of the Esomeprazole microsphere, a 32 factorial design was used, with polymer amount and rpm being the variables. According to the results of the factorial design investigation, it was found that polymer concentration has a substantial impact on drug release while stirring speed has a large impact on entrapment efficiency. Increased Eudragit L100 concentration caused the medication release to increase from 81.06 to 95.71%. The optimized formulation was then assessed for additional research on surface morphology, particle size, PDI, Zeta potential, percent entrapment efficiency, and in-vitro investigations drug release studies and stability of prepared formulation. According to the results of scanning electron microscopy for the optimised batch, developed microparticles with smooth surfaces and spherical shapes were found. 93.40% drug release and 70.63% drug entrapment efficiency were found in the optimised batch. As a result, the current study's findings indicated that microencapsulation had significant benefits for enhancing Esomeprazole's acid stability. By providing a delayed release effect for a duration of 10 hours and a higher patient compliance rate, developed microspheres were demonstrated to be efficient for protecting drugs in acidic media.
Natural polymers have attracted a great deal of attention for use as potential carriers in site-specific delivery over past decades. Mucoadhesive microspheres are useful tools for nasal drug delivery. To prepare and evaluate mucoadhesive microspheres as mode for nasal delivery of ondansetron using Caesalpinia pulcherrima galactomannan (CPG). Conventional spray-dried CPG nasal microspheres loaded with ondansetron for intranasal drug delivery in order to avoid the first pass metabolism with improved therapeutic efficiency in treatment of nausea and vomiting as an alternative therapy to parenterals. Developed microspheres were evaluated for characteristics like particle size, entrapment efficiency, zeta potential, swelling ability, in-vitro mucoadhesion, in-vitro drug release, DSC, XRD study and histopathological evaluation of tissue. CPG-based ondansetron microspheres were studied in rabbits for screening nasal absorption potential of nasal formulation. Developed nasal microspheres possess entrapment efficiency of 80-89%, higher mucoadhesion of 72-84% across goat nasal mucosa. In-vivo study showed that microspheres based on mucoadhesive polymer were able to promote quick drug absorption as well as enhanced bioavailability of drug. Histopathological studies evaluated biocompatible and nontoxic nature of CPG in nasal cavity. Developed mucoadhesive microspheres by nasal route showed enhancement of bioavailability as compared to oral route in rabbits. CPG-based mucoadhesive microspheres can successfully deliver ondansetron intranasally, sustain its effect, avoid first pass effect, an alternative route of administration to injection and thus enhance systemic bioavailability of ondansetron hydrochloride.
Introduction: The aim of the present study was to study the potential efficacy of antitumor activity of nanoparticles loaded with Deferasirox In the current research work, nanoparticle loaded with Deferasirox were developed and evaluated to study its efficacy using breast cancer cell line. Nanoparticles of Deferasirox were prepared by solvent evaporation method using Ethocel (TM) as a polymer and Kolliphor (R) P 188 as a surfactant. 23 factorial design used with concentration of polymer, concentration of surfactant and rpm as independent variables and percentage of entrapment efficiency and percentage of drug release as dependent variables. All formulations were prepared and evaluated for particle size, spectral studies, thermal studies, drug entrapment efficiency and in-vitro drug dissolution studies. In-vitro cell viability study on breast cancer cell line (MCF-7) was performed by MTT assay Developed nanoparticles possess the particle size 428.3 nm and PDI 0.626. Optimized formulation showed 82.62 +/- 1.04 maximum drug release after 6 h in a controlled manner and entrapment efficiency 72.64 +/- 0.24. The FTIR spectral studies and DSC thermogram indicated that there was no interaction between the drug and polymers used. Thus, Deferasirox nanoparticle formulation showed the anti-tumoral activity against human breast cancer cell line (MCF7) as per outcome of cell line study Nanoparticles of Deferasirox were stable and could be promising drug delivery for cancerous cells.